Memantine Genepharm

Memantine hydrochloride, the active ingredient in Memantine Genepharm, is a NMDA receptor antagonist presented as an oral tablet for oral use. It is used to treat cognitive decline associated with Alzheimer’s disease in adults.

GNH USA supplies Memantine Genepharm as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to strict quality standards and provides regulatory‑compliant shipments to global markets.

Memantine, an NMDA receptor antagonist, is employed in the management of neurodegenerative disorders where glutamate‑mediated excitotoxicity contributes to neuronal loss.

Alzheimer's disease: improves cognition, functional abilities, and global clinical status in patients with moderate to severe disease. Alzheimer's disease (mild to moderate): used as an adjunct to cholinesterase inhibitors to support cognitive function.

Adverse reactions to Memantine Genepharm vary in frequency and severity.

Common Side Effects: - Dizziness - Headache - Constipation - Fatigue

Serious or Rare Side Effects: - Seizures - Severe allergic reaction (anaphylaxis) - Stevens‑Johnson syndrome

Memantine Genepharm should be used with caution in several clinical situations.

Renal impairment: dose adjustment may be required. History of seizures: monitor for increased seizure activity. Cardiovascular disease: use cautiously due to possible blood pressure changes. Concomitant NMDA antagonists: avoid combined use. Pregnancy and breastfeeding: risk unknown, discuss with healthcare provider. Store at room temperature: keep in original packaging, protect from moisture and light.

Memantine may interact with other medicines, requiring attention to avoid adverse outcomes.

Major Interactions (Avoid): - Amantadine: increased risk of neurotoxicity. - Ketamine: additive NMDA blockade. - Other NMDA antagonists: avoid concurrent use.

Moderate Interactions (Monitor Closely): - Anticholinergic agents: may worsen cognitive impairment. - CNS depressants (e.g., benzodiazepines, opioids): may increase dizziness. - Diuretics: may affect serum electrolyte balance.